The purpose of this study is to test the safety, tolerability, and effects of choline in
people with increased risk of Alzheimer's Disease (AD), also known as pre-symptomatic AD.
Choline is a dietary supplement, but is being investigated to see if it has any effects on
the progression to AD.
Phase:
Phase 1
Details
Lead Sponsor:
Paul E Schulz
Collaborators:
Balchem Corporation M.D. Anderson Cancer Center Massachusetts Institute of Technology